14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CD vs OPY: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
OPY Overall Winner
6-Pillar Tally: CD 1 – 5 OPY
Matrix Metrics: CD 1 – 9 OPY
As of Nov 16, 2026, Oppenheimer Holdings, Inc. (OPY) is the stronger overall head-to-head candidate over CD (CD) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CD carries a Unified Composite Score of 46.1/100 (HOLD) at $3.68 (N/M Forward P/E, -187.2% operating margin), whereas OPY carries 60.7/100 (BUY) at $87.58 (10.8x Forward P/E, 21.5% operating margin).
Growth vs. Quality Trade-Off: OPY earns the overall head-to-head edge with a stronger Unified Composite Score (60.7/100 BUY vs. CD 46.1/100 HOLD) and 1.33β · 81% Vol risk profile, whereas CD leads top-line expansion (+98.4% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: CD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 34.2); meanwhile OPY is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CD vs OPY. Trailing 12-month operating profitability (CD -187.2% vs OPY 21.5%) and valuation multiples (CD N/M vs OPY 10.8x Forward P/E) are benchmarked directly in Pillar 4 below.
CD Moat ProfileCyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $576.4M market capitalization and -187.2% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
OPY Moat ProfileScale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $960.6M market capitalization and 21.5% operating margin.
OpEx & R&D Reinvestment70.2% of Rev ($1.18B)
90D Engineering Disclosures0 Published
Investor FAQ CD vs OPY Key Questions & Quantitative Answers
As of Nov 16, 2026, Oppenheimer Holdings, Inc. (OPY) is the stronger overall head-to-head candidate over CD (CD) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CD carries a Unified Composite Score of 46.1/100 (HOLD) at $3.68 (N/M Forward P/E, -187.2% operating margin), whereas OPY carries 60.7/100 (BUY) at $87.58 (10.8x Forward P/E, 21.5% operating margin). Growth vs. Quality Trade-Off: OPY earns the overall head-to-head edge with a stronger Unified Composite Score (60.7/100 BUY vs. CD 46.1/100 HOLD) and 1.33β · 81% Vol risk profile, whereas CD leads top-line expansion (+98.4% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 34.2); meanwhile OPY is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CD leads the Growth & Scale pillar: CD posts +98.4% YoY revenue growth and +0.0% YoY earnings growth on $2.6M TTM revenue (59.8% gross margin, -187.2% operating margin), compared with OPY at -10.4% YoY revenue growth and -75.3% YoY earnings growth on $1.67B TTM revenue (91.7% gross margin, 21.5% operating margin). On trailing 12-month operating scale, CD generates $2.6M in USD-normalized revenue versus $1.67B for OPY. In operating R&D and SG&A reinvestment, CD deploys N/A (0 90-day corporate R&D disclosures) versus 70.2% of Rev ($1.18B) (0 disclosures) for OPY.
OPY screens cheaper on headline valuation multiples. CD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported EBITDA margin), whereas OPY trades at 10.8x Forward P/E, 11.8x Trailing P/E, 12.00x PEG, and 1.1x EV/Revenue (3.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CD (-7.7% ROE) versus OPY (8.9% ROE) capital efficiency.
In options market volatility and institutional positioning, CD carries 126.6% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.58β · 185% Vol realized risk). By comparison, OPY carries 35.2% implied volatility (8th %ile, Compressed (<25th %ile)), a 2.00x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (1.33β · 81% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.